Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-06

FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VEREGEN (sinecatechins) submitted by ANI Pharmaceuticals, under NDA 021902.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEREGEN (sinecatechin)

Snippet

SUPPL AP for VEREGEN (SINECATECHINS)